JP2015513521A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513521A5 JP2015513521A5 JP2014543711A JP2014543711A JP2015513521A5 JP 2015513521 A5 JP2015513521 A5 JP 2015513521A5 JP 2014543711 A JP2014543711 A JP 2014543711A JP 2014543711 A JP2014543711 A JP 2014543711A JP 2015513521 A5 JP2015513521 A5 JP 2015513521A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- carbon atoms
- alkyl
- disorder
- depression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2014543711A JP6415982B2 (ja) | 2012-03-12 | 2013-03-11 | 複素環化合物 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012054467 | 2012-03-12 | ||
| JP2012054467 | 2012-03-12 | ||
| PCT/JP2013/057923 WO2013137479A1 (en) | 2012-03-12 | 2013-03-11 | Decahydroquinoxaline derivatives and analogs thereof |
| JP2014543711A JP6415982B2 (ja) | 2012-03-12 | 2013-03-11 | 複素環化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015513521A JP2015513521A (ja) | 2015-05-14 |
| JP2015513521A5 true JP2015513521A5 (cg-RX-API-DMAC7.html) | 2016-04-21 |
| JP6415982B2 JP6415982B2 (ja) | 2018-10-31 |
Family
ID=48048149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014543711A Active JP6415982B2 (ja) | 2012-03-12 | 2013-03-11 | 複素環化合物 |
Country Status (4)
| Country | Link |
|---|---|
| JP (1) | JP6415982B2 (cg-RX-API-DMAC7.html) |
| AR (1) | AR090312A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW201348215A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013137479A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150368213A1 (en) * | 2014-06-20 | 2015-12-24 | The University of Montana, Missoula, MT | Novel Inhibitors of System Xc- |
| AU2022312844A1 (en) * | 2021-07-13 | 2024-01-04 | Otsuka Pharmaceutical Co., Ltd. | Hydrogenated quinoxalines |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4210941A1 (de) * | 1992-04-02 | 1993-10-07 | Bayer Ag | Neue 9-Fluor-7.oxo-7H-pyrido[1,2,3-d,e][1,4]benzoxacin-6-carbonsäuren und -ester |
| ES2226284T3 (es) * | 1998-04-16 | 2005-03-16 | Pfizer Products Inc. | N-acil y n-aroil-aralquilamidas. |
| IT1312310B1 (it) * | 1999-05-07 | 2002-04-15 | Recordati Ind Chimica E Farma | Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale |
| BRPI0507190A (pt) * | 2004-01-29 | 2007-06-26 | Pfizer Prod Inc | combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores |
| CN101528225B (zh) * | 2006-08-07 | 2013-07-17 | 阿尔巴尼分子研究公司 | 作为5ht3调节剂的2-氨基苯并噁唑羧酰胺 |
| JP2012528871A (ja) * | 2009-06-03 | 2012-11-15 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | メラニン凝集ホルモン受容体1アンタゴニストとしてのビス−ピリジルピリドン類 |
| WO2011068171A1 (ja) * | 2009-12-03 | 2011-06-09 | 第一三共株式会社 | 二環性含窒素飽和へテロ環誘導体 |
| EA024099B1 (ru) * | 2010-09-13 | 2016-08-31 | Оцука Фармасьютикал Ко., Лтд. | Гетероциклические соединения для лечения или профилактики расстройств, вызываемых ослабленной нейротрансмиссией серотонина, норэпинефрина или допамина |
-
2013
- 2013-03-11 WO PCT/JP2013/057923 patent/WO2013137479A1/en not_active Ceased
- 2013-03-11 JP JP2014543711A patent/JP6415982B2/ja active Active
- 2013-03-12 TW TW102108642A patent/TW201348215A/zh unknown
- 2013-03-12 AR ARP130100792A patent/AR090312A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2010339423B9 (en) | Therapeutic compounds and related methods of use | |
| JP2022153616A (ja) | Shp2阻害剤として有用な新規複素環式誘導体 | |
| CA2968242C (en) | 4-oxo-3,4-dihydro-1,2,3-benzotriazines as modulators of gpr139 | |
| TW200526604A (en) | Methods for synthesizing quinolinone compounds | |
| CN105473573B (zh) | 用作激酶抑制剂的咔唑甲酰胺化合物 | |
| EP2726485A1 (en) | Quinazolines as therapeutic compounds and related methods of use | |
| AU2015335783B2 (en) | Tricyclic atropisomer compounds | |
| CN110267945A (zh) | 氰基取代的吲哚化合物及其作为lsd1抑制剂的用途 | |
| US20170342054A1 (en) | Compounds and methods of use thereof | |
| CA2651363A1 (en) | Triazolopyrazine derivatives useful as anti-cancer agents | |
| JP2005521698A (ja) | 新規な三環式化合物 | |
| HUP0301932A2 (hu) | IL-1béta és TNF-a inhibitor benzofenon származékok, ezeket tartalmazó gyógyszerkészítmények és ezek alkalmazása gyógyszerkészítmények elżállítására | |
| JPWO2020017587A5 (cg-RX-API-DMAC7.html) | ||
| TW200914431A (en) | Novel morpholine compounds | |
| TW200916458A (en) | Heterocyclic compounds and methods of use thereof | |
| JP2020511515A5 (cg-RX-API-DMAC7.html) | ||
| JP2017517538A (ja) | Gabaa受容体活性のモジュレーターとしてのイミダゾピリダジン誘導体 | |
| TW201536774A (zh) | 經取代之四氫咔唑及咔唑甲醯胺化合物 | |
| JP2019535825A5 (cg-RX-API-DMAC7.html) | ||
| JP2007500168A5 (cg-RX-API-DMAC7.html) | ||
| CN105722840A (zh) | 作为PI3K、mTOR抑制剂的稠合喹啉化合物 | |
| HRP20151282T1 (hr) | Heterocikliäśki spojevi za lijeäśenje ili prevenciju bolesti izazvanih smanjenom neurotransmisijom serotonina, norepinefrina ili dopamina | |
| EP1987007A1 (en) | 3-aminopyrazolines for treatment of neurodegenerative and psychiatric diseases | |
| JP2005538974A5 (cg-RX-API-DMAC7.html) | ||
| JP2006511498A5 (cg-RX-API-DMAC7.html) |